A study shows large language models can predict immunotherapy responses in liver cancer as accurately as experienced doctors.
Key Details
- 1Research led by Prof. Hai Li at Hefei Institutes systematically assessed LLMs' ability to predict liver cancer treatment response.
- 2LLMs tested: GPT-4, GPT-4o, Google Gemini, DeepSeek, and a hybrid Gemini-GPT model.
- 3Dataset included clinical and imaging data from 186 unresectable HCC patients.
- 4Gemini-GPT matched senior (15+ years) doctor accuracy and surpassed less-experienced clinicians in both speed and accuracy.
- 5Hybrid and logical strategies improved LLM performance and consistency, especially in identifying likely responders to therapy.
- 6Published in the Journal of Medical Systems on May 15, 2025.
Why It Matters
This work demonstrates the emerging capability of LLMs to support and enhance personalized cancer treatment decisions, showing they can complement or even match the expertise of experienced radiologists and oncologists in outcome prediction.
Source
EurekAlert
Related News
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.
•EurekAlert
AI Analyzes 66,000 MRI Scans to Map Body Composition Risks
Researchers used AI to analyze over 66,000 whole-body MRI scans, creating a detailed body composition reference map linked to health risks.